NO902628D0 - Produksjon av pyrrolopyrimidiner og mellomprodukter derav. - Google Patents
Produksjon av pyrrolopyrimidiner og mellomprodukter derav.Info
- Publication number
- NO902628D0 NO902628D0 NO902628A NO902628A NO902628D0 NO 902628 D0 NO902628 D0 NO 902628D0 NO 902628 A NO902628 A NO 902628A NO 902628 A NO902628 A NO 902628A NO 902628 D0 NO902628 D0 NO 902628D0
- Authority
- NO
- Norway
- Prior art keywords
- pyrrolopyrimidines
- intermediates
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/50—Three nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15091089 | 1989-06-14 | ||
JP24297589 | 1989-09-18 | ||
JP9239190 | 1990-04-06 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO902628D0 true NO902628D0 (no) | 1990-06-13 |
NO902628L NO902628L (no) | 1990-12-17 |
NO177057B NO177057B (no) | 1995-04-03 |
NO177057C NO177057C (no) | 1995-07-12 |
Family
ID=27307029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO902628A NO177057C (no) | 1989-06-14 | 1990-06-13 | Fremgangsmåte for fremstilling av pyrrolopyrimidiner og mellomprodukter derav |
Country Status (8)
Country | Link |
---|---|
US (2) | US5349064A (no) |
EP (1) | EP0402903A1 (no) |
JP (1) | JP2983254B2 (no) |
KR (1) | KR0162492B1 (no) |
CN (1) | CN1051306C (no) |
CA (1) | CA2018875C (no) |
HU (1) | HU205358B (no) |
NO (1) | NO177057C (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0492316A1 (en) * | 1990-12-14 | 1992-07-01 | Takeda Chemical Industries, Ltd. | Condensed heterocyclic oligoglutamate derivatives, their production and pharmaceutical compositions containing them |
ATE147386T1 (de) * | 1991-08-12 | 1997-01-15 | Takeda Chemical Industries Ltd | Kondensierte pyrimidinderivate, ihre herstellung und ihre verwendung als antitumormittel |
EP0549291A1 (en) * | 1991-12-27 | 1993-06-30 | Takeda Chemical Industries, Ltd. | Thymidylate synthase inhibitors |
US5502187A (en) * | 1992-04-03 | 1996-03-26 | The Upjohn Company | Pharmaceutically active bicyclic-heterocyclic amines |
US5278307A (en) * | 1992-09-25 | 1994-01-11 | Eli Lilly And Company | Process for preparing 4-hydroxypyrrolo(2,3-d)pyrimidine based antifolate compounds and intermediates |
IL107041A (en) * | 1992-09-25 | 2000-02-17 | Lilly Co Eli | Process for preparing omega(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo-6-¬2,3-d¾pyrimidin-5-YL)alkarylcarboxylic acids and N-(omega-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo¬2,3-d¾pyrimidin-5-YL)alk-aroyl-4-glutamic acids |
US5416211A (en) * | 1992-09-25 | 1995-05-16 | Eli Lilly And Company | Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines |
US5834469A (en) * | 1994-06-09 | 1998-11-10 | Smithkline Beecham Corporation | Endothelin receptor antagonists |
JP2000516961A (ja) * | 1996-08-30 | 2000-12-19 | イーライ・リリー・アンド・カンパニー | 非古典的ピロロ[2,3―d]ピリミジン抗葉酸物質 |
US7863444B2 (en) | 1997-03-19 | 2011-01-04 | Abbott Laboratories | 4-aminopyrrolopyrimidines as kinase inhibitors |
CA2304656A1 (en) * | 1997-09-26 | 1999-04-08 | Eli Lilly And Company | Processes and intermediates useful to make antifolates |
PA8474101A1 (es) * | 1998-06-19 | 2000-09-29 | Pfizer Prod Inc | Compuestos de pirrolo [2,3-d] pirimidina |
US6713474B2 (en) | 1998-09-18 | 2004-03-30 | Abbott Gmbh & Co. Kg | Pyrrolopyrimidines as therapeutic agents |
TR200101395T2 (tr) * | 1998-09-18 | 2001-11-21 | Basf Ag. | Kinaz engelleyiciler olarak 4-Aminopyrrolopyrimidin'ler |
US7071199B1 (en) | 1999-09-17 | 2006-07-04 | Abbott Gmbh & Cco. Kg | Kinase inhibitors as therapeutic agents |
SK3812002A3 (en) | 1999-09-17 | 2003-09-11 | Abbott Gmbh & Co Kg | Pyrazolopyrimidines as therapeutic agents |
WO2001042246A2 (en) | 1999-12-10 | 2001-06-14 | Pfizer Products Inc. | PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
EP1572213A1 (en) * | 2002-11-26 | 2005-09-14 | Pfizer Products Inc. | Method of treatment of transplant rejection |
WO2008144694A1 (en) * | 2007-05-21 | 2008-11-27 | Bol Stephen J | Wheel mounted pump for self-inflated tires |
RU2493157C2 (ru) * | 2008-08-20 | 2013-09-20 | Пфайзер Инк. | ПРОИЗВОДНЫЕ ПИРРОЛО[2,3-d]ПИРИМИДИНА |
US8385364B2 (en) * | 2008-09-24 | 2013-02-26 | Nec Laboratories America, Inc. | Distributed message-passing based resource allocation in wireless systems |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB812366A (en) * | 1955-08-18 | 1959-04-22 | Wellcome Found | Improvements in and relating to derivatives of pyrimidine and the preparation thereof |
GB8625019D0 (en) * | 1986-10-18 | 1986-11-19 | Wellcome Found | Compounds |
US4871743A (en) * | 1988-01-19 | 1989-10-03 | The Trustees Of Princeton University | L-glutamic acid derivatives |
JP2830008B2 (ja) * | 1988-04-01 | 1998-12-02 | 武田薬品工業株式会社 | 縮合ピリミジン誘導体 |
NO169490C (no) * | 1988-03-24 | 1992-07-01 | Takeda Chemical Industries Ltd | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater |
-
1990
- 1990-06-12 JP JP2153107A patent/JP2983254B2/ja not_active Expired - Lifetime
- 1990-06-13 EP EP19900111208 patent/EP0402903A1/en not_active Ceased
- 1990-06-13 CA CA002018875A patent/CA2018875C/en not_active Expired - Fee Related
- 1990-06-13 NO NO902628A patent/NO177057C/no not_active IP Right Cessation
- 1990-06-14 KR KR1019900008757A patent/KR0162492B1/ko not_active IP Right Cessation
- 1990-06-14 HU HU903853A patent/HU205358B/hu not_active IP Right Cessation
-
1993
- 1993-03-08 US US08/029,310 patent/US5349064A/en not_active Expired - Fee Related
-
1994
- 1994-01-06 CN CN94100602A patent/CN1051306C/zh not_active Expired - Fee Related
- 1994-06-09 US US08/257,512 patent/US5496946A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5349064A (en) | 1994-09-20 |
CN1103401A (zh) | 1995-06-07 |
CN1051306C (zh) | 2000-04-12 |
HU903853D0 (en) | 1990-11-28 |
JP2983254B2 (ja) | 1999-11-29 |
CA2018875C (en) | 2000-10-31 |
CA2018875A1 (en) | 1990-12-14 |
JPH049383A (ja) | 1992-01-14 |
EP0402903A1 (en) | 1990-12-19 |
NO902628L (no) | 1990-12-17 |
NO177057B (no) | 1995-04-03 |
US5496946A (en) | 1996-03-05 |
KR0162492B1 (ko) | 1998-12-01 |
HU205358B (en) | 1992-04-28 |
KR910000736A (ko) | 1991-01-30 |
NO177057C (no) | 1995-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO902628L (no) | Produksjon av pyrrolopyrimidiner og mellomprodukter derav. | |
NO883535D0 (no) | Fremstilling av mikrokrystallinsk boehmitt og derav fremstilte produkter. | |
NO960552D0 (no) | Elektrode og fremstilling av elektroden | |
PT86196A (pt) | Pulseira magnetica aperfeicoada | |
DE69015990T2 (de) | Kompresse und Herstellungsmethode der Kompresse. | |
IT1219369B (it) | Specchio decorativo e procedimento per la sua fabbricazione | |
FI883382A (fi) | Anvaendning av olefinfoereningar. | |
FI882265A (fi) | Foerfarande foer bestaemning av fruktosamin. | |
NO890661D0 (no) | Fremstilling av antihyperkolesteroltetrazolforbindelser og mellomprodukter derav. | |
PT87674A (pt) | Phenol derivatives their production and use | |
DK450688A (da) | Konditioneringsmidler og fremstilling deraf | |
NO171463C (no) | Fremgangsmaate for fremstilling og montering av flytebro e.l. | |
KR890700427A (ko) | 세라믹 제품 및 이의 제조방법 | |
NO881902D0 (no) | Sopparoma og fremstilling derav. | |
DE69002496D1 (de) | Herstellung von fluorphenolen. | |
NO159183C (no) | Fremgangsmaate for fremstilling av lenser og liknende. | |
ES2019251A4 (es) | Produccion de alfa-cloro-alfa-oximino-4-hidroxilo acetofenona. | |
NO880368L (no) | Acylering og sulfonering av silylketenacetaler. | |
DE69011565D1 (de) | Herstellung von Pre-Kaseinaten und Verwendung. | |
NO901421D0 (no) | Intranasal administrering av fysostigmin og arecolin. | |
TR24296A (tr) | Ferrokrom ueretimine mahsus usul ve tertibat | |
NO892652D0 (no) | Derivater av 19-norprogesteron samt fremstilling og bruk derav. | |
KR890000165U (ko) | 귀걸이 | |
FI920227A0 (fi) | Foerfarande foer framstaellning av 4-demetoxi-4-aminoantracykliner. | |
NO893292D0 (no) | Produksjon av kraftfor. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN DECEMBER 2001 |